Britannia Pharma appoints marketing director

pharmafile | March 18, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing britannia 

Britannia Pharmaceuticals (part of the STADA Arzneimittel group of companies) has appointed Robert Wood as marketing director, for international markets.  

Wood was previously director partners, EMEA at Britannia, and as part of the company’s expansion takes up the new position of marketing director with immediate effect.

Wood has 15 years’ experience in the industry and prior to joining Britannia early in 2011, began his career at Johnson & Johnson Neurosurgical. He has also held the position of Business Unit director, Pharmaceuticals at International SOS and vice president of Business Development at Optasia Medical.

Advertisement

He said: “I am delighted to be continuing to work with Britannia Pharmaceuticals in this new global role, particularly at this incredibly interesting time for the APO-go therapy. The initiation of clinical trials to increase the evidence base for both motor and non-motor effects of APO-go in Parkinson’s disease and the development of new delivery devices, mean APO-go will provide an excellent treatment option for many more people with Parkinson’s.”

Related Content

No items found
The Gateway to Local Adoption Series

Latest content